The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global probiotics market reached a value of US$ 54.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 86.44 Billion by 2027, exhibiting a CAGR of 7.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Probiotics are live microorganisms like bacteria and yeast, which are ingested or administered in the body to prevent and treat certain health conditions. These conditions include curing diarrhea, constipation, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), yeast infections, urinary tract infections, gum disease, lactose intolerance, eczema, upper respiratory infections, and sepsis. Probiotics aid in weight loss, improving digestion, strengthening the immune function, and obtaining healthy skin. As a result, probiotics are added to different drugs, beverages, food products and dietary supplements that are consumed around the world.
There is present a considerable increase in the prevalence of lifestyle and chronic diseases globally. Consequently, there is a rise in the adoption of preventive healthcare, involving annual check-ups, immunizations, flu shots and the consumption of dietary supplements, among individuals on account of the development of efficient probiotic strains. This represents one of the key factors driving the market. Moreover, governments of several countries are implementing stringent regulations to use probiotics in nutraceuticals and nutricosmetics across the globe. This, coupled with the increasing utilization of probiotics in infant products, is propelling the growth of the market. In addition, the rising demand for probiotics as an immunity booster to offer robust protection against gastrointestinal pathogens and promote the production of natural antibodies in the body is positively influencing the market. Besides this, the increasing popularity of strains as a natural, cost-effective, and safe substitute for pharmacological solutions is offering lucrative growth opportunities to industry investors. Additionally, key market players are extensively investing in research and development (R&D) activities to develop plant-based probiotics, which is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global probiotics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on ingredient, distribution channel, application and form.
Breakup by Ingredient:
Breakup by Distribution Channel:
Breakup by Application:
Breakup by Form:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestlé S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Ingredient, Distribution Channel, Application, Form, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestlé S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at